共 50 条
Evidence of Chinese herbal medicine Duhuo Jisheng decoction for knee osteoarthritis: a systematic review of randomised clinical trials
被引:58
|作者:
Zhang, Wenming
[1
]
Wang, Shangquan
[2
]
Zhang, Ranxing
[3
]
Zhang, Yuanyuan
[1
]
Li, Xinjian
[1
]
Lin, Yanping
[1
]
Wei, Xu
[4
]
机构:
[1] Fujian Univ Tradit Chinese Med, Acad Integrat Med, Fuzhou, Fujian, Peoples R China
[2] China Acad Chinese Med Sci, Wangjing Hosp, Dept Gen Orthoped, Beijing, Peoples R China
[3] China Acad Chinese Med Sci, Wangjing Hosp, Clin Lab, Beijing, Peoples R China
[4] China Acad Chinese Med Sci, Wangjing Hosp, Dept Sci Res, Beijing, Peoples R China
来源:
基金:
中国国家自然科学基金;
关键词:
QUALITY-OF-LIFE;
OARSI RECOMMENDATIONS;
MANAGEMENT;
HIP;
PREVALENCE;
GUIDELINES;
EFFICACY;
PROLIFERATION;
CHONDROCYTES;
POPULATION;
D O I:
10.1136/bmjopen-2015-008973
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Objectives: Duhuo Jisheng decoction (DJD) is considered beneficial for controlling knee osteoarthritis (KOA)/related symptoms in some Asian countries. This review compiles the evidence from randomised clinical trials and quantifies the effects of DJD on KOA. Designs: 7 online databases were investigated up to 12 October 2015. Randomised clinical trials investigating treatment of KOA for which DJD was used either as a monotherapy or in combination with conventional therapy compared to no intervention, placebo or conventional therapy, were included. The outcomes included the evaluation of functional activities, pain and adverse effect. The risk of bias was evaluated using the Cochrane Collaboration tool. The estimated mean difference (MD) and SMD was within a 95% CI with respect to interstudy heterogeneity. Results: 12 studies with 982 participants were identified. The quality presented a high risk of bias. Meta- analysis found that DJD combined with glucosamine (MD 4.20 (1.72 to 6.69); p<0.001) or DJD plus meloxicam and glucosamine (MD 3.48 (1.59 to 5.37); p<0.001) had a more significant effect in improving Western Ontario and McMaster Universities Arthritis Index (total WOMAC scores). Also, meta-analysis presented more remarkable pain improvement when DJD plus sodium hyaluronate injection (MD 0.89 (0.26 to 1.53); p=0.006) was used. These studies demonstrated that active treatment of DJD in combination should be practiced for at least 4 weeks. Information on the safety of DJD or comprehensive therapies was insufficient in few studies. Conclusions: DJD combined with Western medicine or sodium hyaluronate injection appears to have benefits for KOA. However, the effectiveness and safety of DJD is uncertain because of the limited number of trials and low methodological quality. Therefore, practitioners should be cautious when applying DJD in daily practice. Future clinical trials should be well designed; more research is needed.
引用
收藏
页数:11
相关论文